NRO-1

Neuroptika announces enrollment of first patient in phase 2 clinical trial for dry eye disease
Pharmaceutical Business Review
Fri, 01/17/20 - 12:05 pm
Neuroptika
dry eye disease
NRO-1
clinical trials